Bradykinin-potentiating peptides from the venom of Agkistrodon halys. Isolation of five bradykinin potentiators and the amino acid sequences of two of them, potentiators B and C

“…ACE plays an essential role in the renin-angiotensin system (RAS), which regulates both arterial blood pressure and the salt/water balance [24,25] . Since the first generation of ACE inhibitors was discovered from snakes, inhibitors of ACE have been a major target for discovering anti-hypertensive drugs [26][27][28][29] . AChE is a key enzyme that breaks down the neurotransmitter acetylcholine at the synaptic cleft.…”

Section: Target Preparationmentioning

confidence: 99%

Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets

Chen

Zhang

et al. 2009

Acta Pharmacol Sin

View full text Add to dashboard Cite

Aim: This study was conducted to compare the efficiencies of two virtual screening approaches, pharmacophore-based virtual screening (PBVS) and docking-based virtual screening (DBVS) methods. Methods: All virtual screens were performed on two data sets of small molecules with both actives and decoys against eight structurally diverse protein targets, namely angiotensin converting enzyme (ACE), acetylcholinesterase (AChE), androgen receptor (AR), D-alanyl-D-alanine carboxypeptidase (DacA), dihydrofolate reductase (DHFR), estrogen receptors α (ERα), HIV-1 protease (HIV-pr), and thymidine kinase (TK). Each pharmacophore model was constructed based on several X-ray structures of protein-ligand complexes. Virtual screens were performed using four screening standards, the program Catalyst for PBVS and three docking programs (DOCK, GOLD and Glide) for DBVS. Results: Of the sixteen sets of virtual screens (one target versus two testing databases), the enrichment factors of fourteen cases using the PBVS method were higher than those using DBVS methods. The average hit rates over the eight targets at 2% and 5% of the highest ranks of the entire databases for PBVS are much higher than those for DBVS. Conclusion: The PBVS method outperformed DBVS methods in retrieving actives from the databases in our tested targets, and is a powerful method in drug discovery. discovery, especially in the cases when no three-dimensional (3D) structural information on the protein target of interest is available. Even when the 3D structures of targets are known, PBVS is also used as a complementary approach to DBVS for pre-processing databases (libraries) of small molecules to remove compounds not possessing features known to be essential for binding or for post-filtering compounds selected by docking approaches [5] . A recent case study by Muthas et al indicated that post-filtering with pharmacophores was shown to increase enrichment rates in their investigated targets compared with docking alone [6] . Several studies have been performed to assess various DBVS methods and compare which docking programs are the most successful in identifying active hits [7][8][9][10] . The conclusion is that no docking program may outperform other docking programs for all the tested targets, and the performance of each tested docking program is highly dependent on the nature of the target binding site [5] .Nevertheless, few case studies for a direct comparison on the performances between PBVS and DBVS have been reported [11] . To gain a general view for the discrimination between these two types of approach in prioritizing actives from a database with decoys, we performed a benchmark comparison between the performances of PBVS and DBVS. Eight structurally diverse protein targets were selected in this study. The pharmacophore models were generated from the ligand co-crystallized complex structures of these targets using the LigandScout program [12] , and each PBVS was performed using the program Catalyst [13,14] . To avoid the target dependency of docking pro...

show abstract

“…Inhibitors of ACE were first obtained from the venom of snakes such as Bothrops jararaca I • 2 ) and Agkistrodon halys blomhoffii. 3 ) Later, Oshima et a/. found peptide inhibitors of ACE in digests of gelafin with bacterial collagenase.…”

mentioning

confidence: 99%

A Peptide Inhibitor of Angiotensin I Converting Enzyme in the Tryptic Hydrolysate of Casein

Maruyama¹,

Suzuki²

1982

Agricultural and Biological Chemistry

View full text Add to dashboard Cite

Bradykinin-potentiating peptides from the venom of Agkistrodon halys. Isolation of five bradykinin potentiators and the amino acid sequences of two of them, potentiators B and C

Cited by 164 publications

References 29 publications

Angiotensin I-Converting Enzyme Inhibitor Derived from an Enzymatic Hydrolysate of Casein. II. Isolation and Bradykinin-potentiating Activity on the Uterus and the Ileum of Rats

Angiotensin I-Converting Enzyme Inhibitor Derived from an Enzymatic Hydrolysate of Casein. II. Isolation and Bradykinin-potentiating Activity on the Uterus and the Ileum of Rats

Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets

A Peptide Inhibitor of Angiotensin I Converting Enzyme in the Tryptic Hydrolysate of Casein

Contact Info

Product

Resources

About